Records containing: Irritable Bowel Syndrome With Diarrhea
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study results posted · 2026-06-30The Role of Fiber in the Prevention and Treatment of Fecal Incontinence
-
CLINICAL_TRIALS study results posted · 2026-06-08Direct Measurement of Gastrointestinal Permeability Change in Response to Aquamin®
-
CLINICAL_TRIALS study record update · 2026-01-12The Role of Breath Testing in Enriching the Likelihood of Response to Rifaximin in Patients With Diarrhea IBS
-
CLINICAL_TRIALS study record update · 2025-12-15A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Study to Evaluate the Efficacy, Safety, and Tolerability of CIN-103 in Adults With Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D)
-
CLINICAL_TRIALS study record update · 2025-11-24The Effects of Fructans in Irritable Bowel Syndrome
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-09-02Effect of Consuming a Nutraceutical Composition Based on Pineapple and Natural Extracts on Signs and Symptoms in Adult Patients With Irritable Bowel Syndrome
-
CLINICAL_TRIALS study record update · 2025-07-14A Randomized Single-Blind Controlled Trial Comparing the Efficacy of Nitazoxanide Versus Rifaximin in Adult Patients With Irritable Bowel Syndrome Without Constipation
-
CLINICAL_TRIALS study record update · 2025-07-10Evaluation of Butyrate and Palmitoylethanolamide Effects on Intestinal Permeability and Microbiota Gut Composition in Patients With Irritable Bowel Syndrome - A Double-blind, Placebo-controlled Crossover Randomized Study
-
CLINICAL_TRIALS study record update · 2025-06-24Pilot Study - The Effect of Bioactive Compounds N-trans-Caffeoyltyramine (NCT) and N-trans-Feruloyltyramine (NFT) on Intestinal Barrier Function in Participants With Irritable Bowel Syndrom With Diarrhoea
-
CLINICAL_TRIALS study record update · 2025-06-05A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Irritable Bowel Syndrome
-
CLINICAL_TRIALS study record update · 2025-05-13The Role of Fiber in the Prevention and Treatment of Fecal Incontinence
-
CLINICAL_TRIALS study record update · 2025-04-03A Multicenter, Randomized, Double-blind, Placebo Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Live SK08 Powder (Bacteroidetes Fragilis) in the Treatment of Patients With Irritable Bowel Syndrome With Diarrhea (IBS-D)
-
CLINICAL_TRIALS study record update · 2025-03-06Evaluating the Safety and Efficacy of a Probiotic on IBS Symptom Severity in Adults With Diarrhoea-predominant Irritable Bowel Syndrome
-
CLINICAL_TRIALS study record update · 2025-02-24Direct Measurement of Gastrointestinal Permeability Change in Response to Aquamin®
-
CLINICAL_TRIALS study record update · 2024-07-31Interest of Pan Capsule (Small Bowel and Colon Video Capsule) in Symptomatic Patients Suspected of Irritable Bowel Syndrome Requiring Colonoscopy Phase A Feasibility
-
CLINICAL_TRIALS study record update · 2024-07-16Efficacy and Safety of Fecal Microbiota Transplantation for the Treatment of Irritable Bowel Syndrome With Diarrhea (IBS-D) and Mental Health Comorbidity in Young Adults: A Randomized, Double-blind, Placebo Controlled Study
-
CLINICAL_TRIALS study record update · 2024-05-24Faecal Microbiota Transplantation in Irritable Bowel Syndrome: a Randomised, Double-blind Cross-over Study Utilising Mixed Microbiota From Healthy Donors
-
CLINICAL_TRIALS study record update · 2024-04-30Effect of Self- Administered Acupressure on Diarrhea Predominant Irritable Bowel Syndrome Patients' Health Outcomes: a Double Blind- Sham Controlled Randomized Clinical Trial
-
CLINICAL_TRIALS study record update · 2023-10-12A Randomized, Double-Blind, Placebo Controlled Trial of Aldafermin (NGM282) for Treatment of Chronic Diarrhea Due to Bile Acid Malabsorption (BAM)
-
CLINICAL_TRIALS study record update · 2023-09-08Evaluating the Safety and Efficacy of the Probiotic Bifidobacterium Longum ES1 and the Post Biotic Heat-treated Bifidobacterium Longum ES1 (HT-ES1) on IBS Symptom Severity in Patients With Diarrhoea Predominant Irritable Bowel Syndrome
-
CLINICAL_TRIALS study record update · 2023-07-27To Compare the Efficacy of (Rifaximin + Mebeverine), (Rifaximin + Amitriptyline), and (Rifaximin + Psyllium Husk) in Irritable Bowel Syndrome Associated With Diarrhea
-
CLINICAL_TRIALS study record update · 2023-07-11FODMAP Reintroduction in Irritable Bowel Syndrome
-
CLINICAL_TRIALS study record update · 2023-04-11Mediterranean Diet Adjusted to Low FODMAP Diet (MED-LFD) vs NICE Guidelines for Improving IBS Symptoms: a New Approach for Managing IBS
-
CLINICAL_TRIALS study record update · 2023-03-28Evaluation of the Efficacy and Safety of Rifaximin in Combination With N-acetylcysteine (NAC) in Adult Patients With Irritable Bowel Syndrome With Diarrhea
-
CLINICAL_TRIALS study record update · 2023-03-06Evaluation of the Effectiveness and Safety of Lactobacillus Fermentum and Lactobacillus Delbrueckii (Lactobacillus LB) in the Treatment of Patients With Irritable Bowel Syndrome With Predominance of Diarrhea (IBS-D)